Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Tilray, Inc.
  6. News
  7. Summary
    TLRY   US88688T1007

TILRAY, INC.

(TLRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Tilray, Inc. Appoints Jim Meiers as Chief Operations Officer

10/19/2021 | 07:30am EST

Tilray, Inc. announced appointment of Jim Meiers as Chief Operations Officer.


ę S&P Capital IQ 2021
All news about TILRAY, INC.
09:53aCannabis company Tilray buys Breckenridge Distillery in move to grow U.S. business
AQ
08:29aIntelGenx Initiates Arbitration Proceeding Against Tilray Over Alleged Breach of Cannab..
MT
08:09aINTELGENX BRIEF : Says Initiated Arbitration Proceeding Against Tilray Related to Alleged ..
MT
07:37aTilray Acquires Colorado-based Breckenridge Distillery; Shares Up More Than 1% in US Pr..
MT
07:04aTILRAY BRIEF : Says Strengthens Strategic Position in the U.S. with Acquisition of Brecken..
MT
07:01aTilray Strengthens Strategic Position in the U.S. with Acquisition of Breckenridge Dist..
GL
06:05aTILRAY, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
12/06Toronto index up as energy stocks boost
RE
12/03Toronto index turns negative as pot producers weigh
RE
12/02Tilray Launches Fast-Acting Medical Cannabis Oral Strips
MT
More news
Analyst Recommendations on TILRAY, INC.
More recommendations
Financials (USD)
Sales 2022 758 M - -
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 4 374 M 4 374 M -
Capi. / Sales 2022 5,77x
EV / Sales 2023
Nbr of Employees 2 100
Free-Float 98,6%
Chart TILRAY, INC.
Duration : Period :
Tilray, Inc. Technical Analysis Chart | TLRY | US88688T1007 | MarketScreener
Technical analysis trends TILRAY, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Last Close Price 9,44 $
Average target price 13,92 $
Spread / Average Target 47,5%
EPS Revisions
Managers and Directors
Irwin David Simon Chairman & Chief Executive Officer
Carl A. Merton Chief Financial Officer
Joshua Eades Chief Science Officer
Catherine Jacobson Vice President-Regulatory & Medical Affairs
Lloyd Brathwaite Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
TILRAY, INC.14.29%4 374
JOHNSON & JOHNSON3.80%430 061
ROCHE HOLDING AG19.17%324 115
PFIZER, INC.39.85%290 297
NOVO NORDISK A/S70.26%250 392
ELI LILLY AND COMPANY45.17%222 215